3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Rectal Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
6
Pancreatic Neoplasms
5
Esophageal Neoplasms
5
Colonic Neoplasms
5
Breast Neoplasms
5
Keratosis, Actinic
4
Nasopharyngeal Neoplasms
3
Nasopharyngeal Carcinoma
3
Carcinoma, Hepatocellular
3
Recurrence
2
Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Uterine Cervical Neoplasms
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Locally Advanced Rectal Cancer
1
Keratosis
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
1
Advanced Colorectal Cancer
1
Interventions
Zidovudine
3
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Methotrexate
2
Leucovorin
2
Electrocoagulation
2
Dexamethasone
2
Watchful Waiting
1
Vincristine
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Therapeutics
1
Self Care
1
Rapid Diagnostic Tests
1
Occult Blood
1
Observation
1
Mammography
1
Inosine Pranobex
1
Fluorouracil
1
Enzyme-Linked Immunosorbent Assay
1
Doxorubicin
1
Cytarabine
1
Cyclophosphamide
1
Bleomycin
1
Biopsy
1
Benzethonium
1
Amyloid
1
Allopurinol
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Acquired Immunodeficiency Syndrome
×
Fluorouracil
×
Clear all
NCT05413811
2026-02-17
ACT2
UNC Lineberger Comprehensive Cancer Center
Phase NA
Completed
180 enrolled